<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28981" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Septic Shock</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mahapatra</surname>
            <given-names>Sidharth</given-names>
          </name>
          <aff>University of Nebraska Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Heffner</surname>
            <given-names>Alan C.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sidharth Mahapatra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Alan Heffner declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28981.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Sepsis syndromes span a clinical continuum with variable prognoses. Septic shock, the most severe complication of sepsis, carries a high mortality. Septic shock occurs in response to an inciting agent, which causes both pro-inflammatory and anti-inflammatory immune system activation. This occurs in concert with the activation of monocytes, macrophages, and neutrophils that interact with the endothelium through pathogen recognition receptors and lead to further involvement of cytokines, proteases, kinins, reactive oxygen species, and nitric oxide. As the primary site of this response, the endothelium not only suffers microvascular injury but also activates the coagulation and complement cascades, which further exacerbate the vascular injury, leading to capillary leakage. This cascade of events is responsible for the clinical signs and symptoms of sepsis and progression from sepsis to septic shock. Striking a balance between pro-inflammatory responses, which help eradicate the invading microorganism, and anti-inflammatory signals, which keep the inflammatory cascade in check, ultimately determines the degree of morbidity and/or mortality of patients with sepsis. Judicious and early antimicrobial administration, sepsis care bundle use, and early goal-directed therapies have significantly and positively impacted sepsis-related mortality. However, early identification remains the best therapeutic tool for sepsis treatment and management. This activity describes the evaluation and management of septic shock and highlights the role of the interprofessional team in enhancing care delivery for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the causes of septic shock.</p></list-item><list-item><p>Describe the pathophysiology of septic shock.</p></list-item><list-item><p>Outline the treatment options for septic shock.</p></list-item><list-item><p>Explain the importance of improving care coordination amongst interprofessional team members to improve outcomes for patients affected by septic shock.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28981&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28981">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28981.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Sepsis syndromes span a clinical continuum with variable prognoses. Septic shock, the most severe complication of sepsis, carries high mortality. In response to an inciting agent, pro-inflammatory and anti-inflammatory arms of the immune system are activated in concert with the activation of monocytes, macrophages, and neutrophils that interact with the endothelium through pathogen recognition receptors to elaborate cytokines, proteases, kinins, reactive oxygen species, and nitric oxide.<xref ref-type="bibr" rid="article-28981.r1">[1]</xref> As the primary site of this response, the endothelium not only suffers microvascular injury but also activates the coagulation and complement cascades, which further exacerbate vascular injury, leading to capillary&#x000a0;leak. This cascade of events is responsible for the clinical signs and symptoms of sepsis and progression from sepsis to septic shock. The ability to balance pro-inflammatory responses to eradicate the invading microorganism with anti-inflammatory signals set to control the overall inflammatory cascade ultimately determines the degree of morbidity and/or mortality experienced by the patient. Judicious and early antimicrobial administration, sepsis care bundle use, and early goal-directed therapies have significantly and positively impacted sepsis-related mortality. However, early identification remains the best therapeutic tool for sepsis treatment and management.</p>
      </sec>
      <sec id="article-28981.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The 2009 European Prevalence of Infection in Intensive Care (EPIC II study) determined that gram-negative bacterial infections far exceed other etiologies as the most common cause of sepsis syndromes, with a frequency of 62%, followed by gram-positive infections at 47%. An increase in the prevalence of the latter may be attributable to the performance of more invasive procedures and increased incidence of nosocomial infections.<xref ref-type="bibr" rid="article-28981.r2">[2]</xref> Predominant micro-organisms isolated in patients include <italic toggle="yes">Staphylococcus aureus</italic> (20%), <italic toggle="yes">Pseudomonas</italic> (20%), and <italic toggle="yes">Escherichia coli</italic> (16%).<xref ref-type="bibr" rid="article-28981.r3">[3]</xref>&#x000a0;Predominant sites of infection include respiratory (42%), bloodstream (21%), and genitourinary (10%).<xref ref-type="bibr" rid="article-28981.r2">[2]</xref> These data need to be assessed in the context of knowing that over a third of patients never grow positive cultures.<xref ref-type="bibr" rid="article-28981.r4">[4]</xref></p>
        <p>The influence of bacterial strain and site of infection on mortality was illustrated in a large meta-analysis.<xref ref-type="bibr" rid="article-28981.r5">[5]</xref> In this study, gram-negative infections were overall associated with higher mortality. However, gram-positive bacteremia with <italic toggle="yes">Acinetobacter</italic> or pneumonia with <italic toggle="yes">Staphylococcus</italic> carried a 40% mortality with <italic toggle="yes">Pseudomonal</italic> pneumonia carrying the highest mortality at 70%.</p>
        <p>Sepsis syndromes caused by multidrug-resistant bacterial strains (methicillin-resistant Staphylococcus (MRSA), vancomycin-resistant&#x000a0;enterococci (VRE)) are on the rise with a current incidence of up to 25%; viruses and parasites cause far fewer cases and are identified in 2% to 4% of cases.<xref ref-type="bibr" rid="article-28981.r6">[6]</xref></p>
        <p>Risk factors that predispose to sepsis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Diabetes</p>
          </list-item>
          <list-item>
            <p>Malignancy</p>
          </list-item>
          <list-item>
            <p>Chronic kidney and liver disease</p>
          </list-item>
          <list-item>
            <p>Use of corticosteroids</p>
          </list-item>
          <list-item>
            <p>Immunosuppressed state</p>
          </list-item>
          <list-item>
            <p>Burns</p>
          </list-item>
          <list-item>
            <p>Major surgery</p>
          </list-item>
          <list-item>
            <p>Trauma</p>
          </list-item>
          <list-item>
            <p>Presence of indwelling catheters</p>
          </list-item>
          <list-item>
            <p>Prolonged hospitalization</p>
          </list-item>
          <list-item>
            <p>Hemodialysis</p>
          </list-item>
          <list-item>
            <p>Extremes of age</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28981.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Annually, the rate of this debilitating condition is rising by almost 9%.<xref ref-type="bibr" rid="article-28981.r7">[7]</xref> The incidence of sepsis and severe sepsis have risen over the past decade from approximately 600,000 to over 1,000,000 hospitalizations per year from 2000 through 2008.<xref ref-type="bibr" rid="article-28981.r8">[8]</xref> Accompanying this trend has been a rise in healthcare expenditure, making sepsis the most expensive healthcare condition in 2009, accounting for 5% of total United States hospital costs.<xref ref-type="bibr" rid="article-28981.r9">[9]</xref> The case fatality for patients with sepsis has been declining due to advances in sepsis management provided by the Surviving Sepsis Campaign. The United States&#x000a0;Nationwide Inpatient Sample (NIS) from 2009 through 2012 showed a mortality rate declined from 16.5% to 13.8%.<xref ref-type="bibr" rid="article-28981.r10">[10]</xref>&#x000a0;However, severe sepsis continues to rank among the most common causes of death in hospitalized patients.<xref ref-type="bibr" rid="article-28981.r11">[11]</xref> Moreover, up to 25% of patients with severe sepsis and 50% of patients with septic shock will suffer mortality.<xref ref-type="bibr" rid="article-28981.r2">[2]</xref> However, overall mortality from sepsis syndromes can vary from 30% to 50% <xref ref-type="bibr" rid="article-28981.r12">[12]</xref>&#x000a0;depending on demographic factors such as age, race, sex, co-morbid conditions, and the presence of organ dysfunction.<xref ref-type="bibr" rid="article-28981.r13">[13]</xref>&#x000a0;For example, in-patient mortality was predicted most by the number and degree of organ injury, with the strongest predictors being respiratory, cardiovascular, hepatic, and neurologic failure.<xref ref-type="bibr" rid="article-28981.r10">[10]</xref></p>
      </sec>
      <sec id="article-28981.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Sepsis is a clinical state that falls along a continuum of pathophysiologic states, starting with a systemic inflammatory response syndrome (SIRS) and ending in multiorgan dysfunction syndrome&#x000a0;(MODS) before death.&#x000a0;</p>
        <p>The earliest signs of inflammation are heralded by the following:</p>
        <list list-type="order">
          <list-item>
            <p>Fever (temperature higher than 38 C or hypothermia (temperature less than 36 C)</p>
          </list-item>
          <list-item>
            <p>Tachycardia (heart rate more than 90 beats per minute),&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Tachypnea (respiratory rate more than 20 breaths per minute)</p>
          </list-item>
          <list-item>
            <p>Leukocytosis (WBC greater than 12,000/cu mm) / leukopenia (white blood cells (WBC) less than 4,000/cu mm) with or without bandemia (more than 10%).</p>
          </list-item>
        </list>
        <p>The presence of two of these four clinical signs is necessary for the diagnosis of&#x000a0;systemic inflammatory response syndrome. After that,&#x000a0;systemic inflammatory response syndrome&#x000a0;with an infectious source suffices the clinical definition for sepsis.<xref ref-type="bibr" rid="article-28981.r14">[14]</xref>&#x000a0;</p>
        <p>With the development of hypotension, tissue demands are not adequately met by tissue oxygenation, and the patient is now defined to be in severe sepsis.<xref ref-type="bibr" rid="article-28981.r14">[14]</xref> The&#x000a0;decline in peripheral vascular perfusion and oxygenation leads to cellular and metabolic derangements, most notably a shift from&#x000a0;aerobic respiration to anaerobic respiration&#x000a0;with ensuing lactic acidosis. Tissue hypoperfusion may also be manifested by signs of end-organ damage, such as pre-renal azotemia or transaminitis.&#x000a0;The difference in oxygen supply and demand can be monitored&#x000a0;during resuscitation by trending the mixed venous oxygen saturation from a central line in the superior vena cava (SVC) when&#x000a0;available.<xref ref-type="bibr" rid="article-28981.r1">[1]</xref></p>
        <p>When sepsis-induced hypotension remains refractory to initial management with fluid resuscitation, septic shock ensues.<xref ref-type="bibr" rid="article-28981.r14">[14]</xref> Septic shock is distinguished from other shock states as a distributive type of shock. The action of a combination of inflammatory mediators (histamine, serotonin, super-radicals, lysosomal enzymes) elaborated&#x000a0;in response to bacterial endotoxins leads to a marked increase in capillary permeability and a concomitant reduction in peripheral vascular resistance. This translates not only into a reduction in afterload but also&#x000a0;in&#x000a0;preload from a decline&#x000a0;in venous return from third-spacing. The resulting reduction in stroke volume is accommodated initially by an elevation in heart rate, i.e., compensated septic shock. As a result,&#x000a0;the patient is in a&#x000a0;hyperdynamic state that is characteristic of septic shock.<xref ref-type="bibr" rid="article-28981.r1">[1]</xref></p>
        <p>Clinically, patients have a dynamic precordium with&#x000a0;tachycardia and bounding peripheral pulses. They are warm to the touch&#x000a0;and&#x000a0;have a reduction in capillary refill (flash cap refill). This is described as warm shock. As shock progresses, elevated catecholamine production leads to an increase in peripheral vascular resistance as the body attempts to shunt blood away from non-vital tissues (gastrointestinal (GI) tract, kidneys, muscle, and skin) to the vital tissues (brain and heart). This is described as cold shock. Understanding&#x000a0;the pathophysiology and continuum of septic shock is imperative in initiating appropriate treatment measures.<xref ref-type="bibr" rid="article-28981.r1">[1]</xref></p>
        <p>Functionally, septic shock is defined by persistent hypotension despite adequate fluid resuscitation from 60&#x000a0;ml/kg to&#x000a0;80 mL/kg of either crystalloid or colloid fluid. At this point, the initiation of appropriate vasoactive medications such as beta-adrenergic or alpha-adrenergic drugs is&#x000a0;of utmost importance. The progression of organ dysfunction despite high-dose vasoactive administration defines the state of multiorgan dysfunction syndrome (MODS), which&#x000a0;carries mortality as high as&#x000a0;75%.&#x000a0;While the exact circumstances predicting poor prognosis and death have been difficult to determine, immunologic dissonance (exaggerated pro-inflammatory response) versus immunologic paralysis (exaggerated anti-inflammatory response) have been purported to play a role.<xref ref-type="bibr" rid="article-28981.r15">[15]</xref></p>
      </sec>
      <sec id="article-28981.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Early Signs and Symptoms</bold>
</p>
        <p>Sepsis is defined as systemic inflammatory response syndrome plus an infectious source. Therefore, earlier on in the presentation of sepsis, patients present with the following vital sign changes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fever, temperature higher than 38 C, or hypothermia, temperature lower than 36 C</p>
          </list-item>
          <list-item>
            <p>Tachycardia with a heart rate higher than 90 beats per minute in adult patients or less than two standard deviations for age in pediatric patients</p>
          </list-item>
          <list-item>
            <p>Tachypnea with respiratory rate greater than 20 breaths per minute in adult patients or more than two standard deviations for age in pediatric patients</p>
          </list-item>
        </list>
        <p><bold>Signs and Symptoms of Severe Sepsis </bold>Severe sepsis is defined as sepsis and end-organ dysfunction. At this stage, signs and symptoms may include:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Altered mental status</p>
          </list-item>
          <list-item>
            <p>Oliguria or anuria</p>
          </list-item>
          <list-item>
            <p>Hypoxia</p>
          </list-item>
          <list-item>
            <p>Cyanosis</p>
          </list-item>
          <list-item>
            <p>Ileus</p>
          </list-item>
        </list>
        <p>Patients progressing to septic shock will experience signs and symptoms of severe sepsis with hypotension. Of note, at an early "compensated" stage of shock, blood pressure may be maintained, and other signs of distributive shock might be present, for example,&#x000a0;warm extremities, flash capillary refill (less than one second), and bounding pulses, also known as&#x000a0;warm shock. This stage of shock, if managed aggressively with fluid resuscitation and vasoactive support, can be reversed. With the progression of septic shock into the uncompensated stage, hypotension ensues, and patients may present with cool extremities, delayed capillary refill (more than three seconds), and thready pulses, also known as&#x000a0;cold shock. After that, with continued tissue hypoperfusion, shock may be irreversible, progressive rapidly into multiorgan dysfunction syndrome&#x000a0;and death.</p>
      </sec>
      <sec id="article-28981.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Laboratory Findings</bold>
</p>
        <p>Findings in sepsis, severe sepsis, and septic shock are as follows&#x000a0;<xref ref-type="bibr" rid="article-28981.r16">[16]</xref>:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Hyperglycemia (glucose more than 120 mg/dL)</p>
          </list-item>
          <list-item>
            <p>Leukocytosis (WBC more than 12,000/mm<sup>3</sup>) or leukopenia (WBC less than 4000/mm<sup>3</sup>)</p>
          </list-item>
          <list-item>
            <p>Bandemia (more than 10%)</p>
          </list-item>
          <list-item>
            <p>C-reactive protein or procalcitonin more than 2 SD above normal</p>
          </list-item>
          <list-item>
            <p>Mixed venous saturation of more than 70%</p>
          </list-item>
          <list-item>
            <p>PaO2: FiO2&#x000a0;less than 300</p>
          </list-item>
          <list-item>
            <p>Pre-renal azotemia</p>
          </list-item>
          <list-item>
            <p>Coagulopathy, INR more than 1.5 or PTT more than 60 sec</p>
          </list-item>
          <list-item>
            <p>Thrombocytopenia (platelets less than 100,000/mL)</p>
          </list-item>
          <list-item>
            <p>Hyperbilirubinemia (total bilirubin more than 4 mg/dL)</p>
          </list-item>
          <list-item>
            <p>Lactic acidosis (more than&#x000a0;2 mmol/L)</p>
          </list-item>
        </list>
        <p>Patients should be placed on continuous cardiopulmonary monitoring to allow close observation of vital signs. A thorough assessment of end-organ function and peripheral perfusion should be undertaken to determine where they may fall along the pathophysiologic continuum of sepsis. This should include a Glasgow Coma Scale (GCS) or mental status assessment, urine output measurement, or lactate/mixed venous saturation determination (with central lines). Regardless of where along the continuum patients are, all patients should have drawn a complete blood count with differential (CBC-d), source cultures (blood, urine, tracheal (if intubated), wound), and a urinalysis. Depending on the severity of presentation and age of the patient, a lumbar puncture may be indicated, for example, in patients with signs of encephalitis or meningitis or febrile pediatric patients under six weeks of age. The addition of C-reactive protein or procalcitonin, both acute-phase proteins, may be helpful in distinguishing viral from bacterial sepsis, with the latter showing steeper elevations in these proteins. A complete chemistry panel with liver function tests, a disseminated intravascular coagulation (DIC) panel, and an arterial blood gas are additional labs that may provide important information on the severity of sepsis syndrome in a patient.</p>
        <p>At least two sets of blood cultures are recommended prior to administration of antibiotics. However, less than 40% of blood cultures are positive.</p>
        <p>A chest x-ray may reveal signs of pneumonia or ARDS. Plain X-rays of the extremities may reveal the presence of gas in tissues if the patient has necrotizing fasciitis. Ultrasound may be used to evaluate the gallbladder. CT scan is used to assess the abdomen for abscess, bowel perforation, or ischemia.</p>
      </sec>
      <sec id="article-28981.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The below guidelines are derived from the Surviving Sepsis Campaign Guidelines&#x000a0;<xref ref-type="bibr" rid="article-28981.r17">[17]</xref><xref ref-type="bibr" rid="article-28981.r18">[18]</xref></p>
        <p>
<bold>Source Control</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Broad-spectrum antibiotics within one hour of diagnosis for all patients. Initial empiric anti-infective therapy should&#x000a0;have activity against all likely pathogens and adequate penetration of source&#x000a0;tissue. &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Removal of infected/necrotic tissue if it is the source of septic shock, ie, patients with cellulitis, abscess, infected devices, or purulent wounds.</p>
          </list-item>
        </list>
        <p>
<bold>Management of Shock </bold>
<xref ref-type="bibr" rid="article-28981.r19">[19]</xref>
</p>
        <list list-type="order">
          <list-item>
            <p>Measures are most effective if achieved within the first six hours of diagnosis.</p>
          </list-item>
          <list-item>
            <p>Restore central venous pressure (CVP) to 8 mmHg to 12 mm Hg</p>
          </list-item>
          <list-item>
            <p>Restore mean arterial pressure (MAP) greater than 65 mm Hg</p>
          </list-item>
          <list-item>
            <p>Restore superior vena cava saturation to 70% or mixed venous saturation to 65%</p>
          </list-item>
          <list-item>
            <p>Fluid resuscitation with crystalloid (NS or albumin) and colloid (blood products) up to 80 ml/kg</p>
          </list-item>
          <list-item>
            <p>Mechanical ventilation to reduce metabolic demand</p>
          </list-item>
          <list-item>
            <p>First-line vasoactive agents (epinephrine in cold shock versus norepinephrine in warm shock) when fluid-refractoryNote: dopamine as a first-line agent has fallen out of favor given its inhibitory effect on the HPA axis, namely prolactin and growth hormone, which can confer immunologic dysfunction <xref ref-type="bibr" rid="article-28981.r20">[20]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Enhancing Host Response</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Corticosteroids indicated in vasoactive-refractory shock and or in patients with low (unstimulated) basal cortisol levels less than 150 &#x003bc;g/L) <xref ref-type="bibr" rid="article-28981.r21">[21]</xref><xref ref-type="bibr" rid="article-28981.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>Addition of vasopressin indicated&#x000a0;in vasoactive-refractory shock</p>
          </list-item>
        </list>
        <p>While central lines are not required for the resuscitation of patients with septic shock, they provide&#x000a0;an accurate&#x000a0;means&#x000a0;of&#x000a0;monitoring CVP and mixed venous oxygen. Remember that CVP and MVO2 are most accurate from a central line that lies within the right atrium;&#x000a0;lower extremity central lines do not provide the most accurate data for monitoring these indices of resuscitation. Regarding the need for central venous access for the administration of vasoactive agents, a recent study showed that both dopamine, norepinephrine, and phenylephrine at high doses could be safely administered&#x000a0;via peripheral venous access.<xref ref-type="bibr" rid="article-28981.r23">[23]</xref>&#x000a0;</p>
        <p>Early goal-directed therapy (EGDT) has not been shown to confer a survival benefit in more recent studies.<xref ref-type="bibr" rid="article-28981.r24">[24]</xref> All studies comparing EGDT to standard practice have shown an increase in the administration of crystalloid and packed red blood cells in the first six hours and the placement&#x000a0;of&#x000a0;central lines. Furthermore, survival&#x000a0;was influenced most by the maintenance of blood pressure independent of the type of fluid or vasoactive used and not CVP or MVO2.<xref ref-type="bibr" rid="article-28981.r25">[25]</xref> That said, the Surviving Sepsis Campaign guidelines continue to support EGDT as the standard of practice for the management of severe sepsis and septic shock.</p>
        <p>The placement of an arterial line becomes important in the management of vasoactive-refractory shock for close monitoring of blood pressure and tissue oxygenation status via regular blood gasses with key attention to lactate levels and pO<sub>2</sub>.</p>
        <p>Patients with sepsis have a high metabolism, and thus, prolonged starvation should be avoided. Early nutrition can help protect gut mucosa and prevent the translocation of organisms from the GI tract into systemic circulation.</p>
      </sec>
      <sec id="article-28981.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>ARDS</p>
          </list-item>
          <list-item>
            <p>DIC</p>
          </list-item>
          <list-item>
            <p>Distributive shock</p>
          </list-item>
          <list-item>
            <p>Hemorrhagic shock</p>
          </list-item>
          <list-item>
            <p>Adrenal crisis</p>
          </list-item>
          <list-item>
            <p>Cardiogenic shock</p>
          </list-item>
          <list-item>
            <p>Toxic shock syndrome</p>
          </list-item>
          <list-item>
            <p>Drug toxicity</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28981.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Septic shock is a serious illness, and despite all the advances in medicine, it still carries high mortality, which can exceed 40%. Mortality does depend on many factors, including the type of organism, antibiotic sensitivity, number of organs affected, and patient age. The more factors that match SIRS, the higher the mortality. Data suggest that tachypnea and altered mental status are excellent predictors of poor outcomes. Finally, prolonged use of inotropes to maintain blood pressure is also associated with adverse outcomes. Even those who survive are left with significant functional and cognitive deficits.</p>
      </sec>
      <sec id="article-28981.s11" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>ARDS</p>
          </list-item>
          <list-item>
            <p>Acute/chronic renal injury</p>
          </list-item>
          <list-item>
            <p>DIC</p>
          </list-item>
          <list-item>
            <p>Mesenteric ischemia</p>
          </list-item>
          <list-item>
            <p>Acute liver failure</p>
          </list-item>
          <list-item>
            <p>Myocardial dysfunction</p>
          </list-item>
          <list-item>
            <p>Multiple organ failure</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28981.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of septic shock is best done with an interprofessional team that includes ICU nurses. The key is early diagnosis and resuscitation to maintain end-organ perfusion. The type of fluid for resuscitation has little bearing on outcomes but the key is to maintain adequate perfusion pressure. Patients with sepsis are prone to many complications, which have high mortality. Thus, close monitoring and prevention of these complications are vital. Primary disorders like diabetes and renal or liver failure must be treated. Drugs that affect the immune system should be discontinued. The dietitian should be consulted as there is good evidence that early enteral nutrition is beneficial. The nurse should ensure DVT and pressure sore prophylaxis. The nurse should also monitor all catheters for infection and remove those that are not needed. The pharmacists should follow culture results and ensure the patient is on organism-sensitive antibiotics. Clinicians should maintain aseptic techniques during procedures, and hand washing should be practiced. The entire team should communicate with each other to ensure that the patient is receiving optimal care.</p>
        <p>The outcomes of septic shock depend on patient age, associated comorbidities, renal function, need for dialysis, requiring mechanical ventilation, and response to treatment.</p>
      </sec>
      <sec id="article-28981.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28981&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28981">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/septic-shock/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28981">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28981/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28981">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28981.s14">
        <title>References</title>
        <ref id="article-28981.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Rivers</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Abrahamian</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Trzeciak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Osborn</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Talan</surname>
                <given-names>DA</given-names>
              </name>
              <collab>Emergency Department Sepsis Education Program and Strategies to Improve Survival (ED-SEPSIS) Working Group</collab>
            </person-group>
            <article-title>Severe sepsis and septic shock: review of the literature and emergency department management guidelines.</article-title>
            <source>Ann Emerg Med</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>28</fpage>
            <page-range>28-54</page-range>
            <pub-id pub-id-type="pmid">16781920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayr</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Yende</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Linde-Zwirble</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Peck-Palmer</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Barnato</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Weissfeld</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis.</article-title>
            <source>JAMA</source>
            <year>2010</year>
            <month>Jun</month>
            <day>23</day>
            <volume>303</volume>
            <issue>24</issue>
            <fpage>2495</fpage>
            <page-range>2495-503</page-range>
            <pub-id pub-id-type="pmid">20571016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vincent</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Rello</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Anzueto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lipman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gomersall</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sakr</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Reinhart</surname>
                <given-names>K</given-names>
              </name>
              <collab>EPIC II Group of Investigators</collab>
            </person-group>
            <article-title>International study of the prevalence and outcomes of infection in intensive care units.</article-title>
            <source>JAMA</source>
            <year>2009</year>
            <month>Dec</month>
            <day>02</day>
            <volume>302</volume>
            <issue>21</issue>
            <fpage>2323</fpage>
            <page-range>2323-9</page-range>
            <pub-id pub-id-type="pmid">19952319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rangel-Frausto</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of bacterial sepsis.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>299</fpage>
            <page-range>299-312, vii</page-range>
            <pub-id pub-id-type="pmid">10340168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cohen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cristofaro</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Carlet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Opal</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>New method of classifying infections in critically ill patients.</article-title>
            <source>Crit Care Med</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>32</volume>
            <issue>7</issue>
            <fpage>1510</fpage>
            <page-range>1510-26</page-range>
            <pub-id pub-id-type="pmid">15241096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Annane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Aegerter</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jars-Guincestre</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Guidet</surname>
                <given-names>B</given-names>
              </name>
              <collab>CUB-R&#x000e9;a Network</collab>
            </person-group>
            <article-title>Current epidemiology of septic shock: the CUB-R&#x000e9;a Network.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2003</year>
            <month>Jul</month>
            <day>15</day>
            <volume>168</volume>
            <issue>2</issue>
            <fpage>165</fpage>
            <page-range>165-72</page-range>
            <pub-id pub-id-type="pmid">12851245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Mannino</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Eaton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moss</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of sepsis in the United States from 1979 through 2000.</article-title>
            <source>N Engl J Med</source>
            <year>2003</year>
            <month>Apr</month>
            <day>17</day>
            <volume>348</volume>
            <issue>16</issue>
            <fpage>1546</fpage>
            <page-range>1546-54</page-range>
            <pub-id pub-id-type="pmid">12700374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r8">
          <label>8</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Elixhauser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Stranges</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <chapter-title>Septicemia in U.S. Hospitals, 2009</chapter-title>
            <source>Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]</source>
            <publisher-name>Agency for Healthcare Research and Quality (US)</publisher-name>
            <publisher-loc>Rockville (MD)</publisher-loc>
            <year>2011</year>
            <month>10</month>
            <pub-id pub-id-type="pmid">22049570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Torio</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <chapter-title>National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011</chapter-title>
            <source>Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]</source>
            <publisher-name>Agency for Healthcare Research and Quality (US)</publisher-name>
            <publisher-loc>Rockville (MD)</publisher-loc>
            <year>2013</year>
            <month>8</month>
            <pub-id pub-id-type="pmid">24199255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elfeky</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Golabi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Otgonsuren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Djurkovic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Younossi</surname>
                <given-names>ZM</given-names>
              </name>
            </person-group>
            <article-title>The epidemiologic characteristics, temporal trends, predictors of death, and discharge disposition in patients with a diagnosis of sepsis: A cross-sectional retrospective cohort study.</article-title>
            <source>J Crit Care</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>39</volume>
            <fpage>48</fpage>
            <page-range>48-55</page-range>
            <pub-id pub-id-type="pmid">28199891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angus</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Linde-Zwirble</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Lidicker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Clermont</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Carcillo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pinsky</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.</article-title>
            <source>Crit Care Med</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>7</issue>
            <fpage>1303</fpage>
            <page-range>1303-10</page-range>
            <pub-id pub-id-type="pmid">11445675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Escobar</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Greene</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Soule</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Whippy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Iwashyna</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Hospital deaths in patients with sepsis from 2 independent cohorts.</article-title>
            <source>JAMA</source>
            <year>2014</year>
            <month>Jul</month>
            <day>02</day>
            <volume>312</volume>
            <issue>1</issue>
            <fpage>90</fpage>
            <page-range>90-2</page-range>
            <pub-id pub-id-type="pmid">24838355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Annane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bellissant</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cavaillon</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Septic shock.</article-title>
            <source>Lancet</source>
            <year>2005</year>
            <month>Jan</month>
            <day>1-7</day>
            <volume>365</volume>
            <issue>9453</issue>
            <fpage>63</fpage>
            <page-range>63-78</page-range>
            <pub-id pub-id-type="pmid">15639681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bone</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Balk</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Cerra</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Dellinger</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Fein</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Knaus</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Schein</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Sibbald</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.</article-title>
            <source>Chest</source>
            <year>1992</year>
            <month>Jun</month>
            <volume>101</volume>
            <issue>6</issue>
            <fpage>1644</fpage>
            <page-range>1644-55</page-range>
            <pub-id pub-id-type="pmid">1303622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hotchkiss</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Karl</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>The pathophysiology and treatment of sepsis.</article-title>
            <source>N Engl J Med</source>
            <year>2003</year>
            <month>Jan</month>
            <day>09</day>
            <volume>348</volume>
            <issue>2</issue>
            <fpage>138</fpage>
            <page-range>138-50</page-range>
            <pub-id pub-id-type="pmid">12519925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levy</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Opal</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ramsay</surname>
                <given-names>G</given-names>
              </name>
              <collab>SCCM/ESICM/ACCP/ATS/SIS</collab>
            </person-group>
            <article-title>2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.</article-title>
            <source>Crit Care Med</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>1250</fpage>
            <page-range>1250-6</page-range>
            <pub-id pub-id-type="pmid">12682500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Puskarich</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>The Surviving Sepsis Campaign guidelines 2012: update for emergency physicians.</article-title>
            <source>Ann Emerg Med</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>63</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-47</page-range>
            <pub-id pub-id-type="pmid">24067755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rhodes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Alhazzani</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sevransky</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Sprung</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Nunnally</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Rochwerg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rubenfeld</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Annane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Beale</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Bellinghan</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Chiche</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Coopersmith</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De Backer</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Fujishima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gerlach</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hidalgo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hollenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Karnad</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Kleinpell</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lisboa</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Machado</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Mazuski</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McIntyre</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>McLean</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Myburgh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Navalesi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nishida</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Osborn</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Perner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Plunkett</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Ranieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schorr</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Seckel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Seymour</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Shieh</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shukri</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>SQ</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Townsend</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Van der Poll</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Wiersinga</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Dellinger</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.</article-title>
            <source>Crit Care Med</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>486</fpage>
            <page-range>486-552</page-range>
            <pub-id pub-id-type="pmid">28098591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rivers</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Havstad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ressler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Muzzin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Knoblich</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tomlanovich</surname>
                <given-names>M</given-names>
              </name>
              <collab>Early Goal-Directed Therapy Collaborative Group</collab>
            </person-group>
            <article-title>Early goal-directed therapy in the treatment of severe sepsis and septic shock.</article-title>
            <source>N Engl J Med</source>
            <year>2001</year>
            <month>Nov</month>
            <day>08</day>
            <volume>345</volume>
            <issue>19</issue>
            <fpage>1368</fpage>
            <page-range>1368-77</page-range>
            <pub-id pub-id-type="pmid">11794169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ventura</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Shieh</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Bousso</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>G&#x000f3;es</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>de C&#x000e1;ssia F O Fernandes</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Paulo</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Chagas</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gilio</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock.</article-title>
            <source>Crit Care Med</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>43</volume>
            <issue>11</issue>
            <fpage>2292</fpage>
            <page-range>2292-302</page-range>
            <pub-id pub-id-type="pmid">26323041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Annane</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroids for septic shock.</article-title>
            <source>Crit Care Med</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>7 Suppl</issue>
            <fpage>S117</fpage>
            <page-range>S117-20</page-range>
            <pub-id pub-id-type="pmid">11445745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Annane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Renault</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bellissant</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Glucocorticoids with or without Fludrocortisone in Septic Shock.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Aug</month>
            <day>30</day>
            <volume>379</volume>
            <issue>9</issue>
            <fpage>895</fpage>
            <page-range>895-6</page-range>
            <pub-id pub-id-type="pmid">30179381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cardenas-Garcia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schaub</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Belchikov</surname>
                <given-names>YG</given-names>
              </name>
              <name>
                <surname>Narasimhan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koenig</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Mayo</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Safety of peripheral intravenous administration of vasoactive medication.</article-title>
            <source>J Hosp Med</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>10</volume>
            <issue>9</issue>
            <fpage>581</fpage>
            <page-range>581-5</page-range>
            <pub-id pub-id-type="pmid">26014852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angus</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Barnato</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bellomo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Coats</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Delaney</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Holdgate</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Howe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Iwashyna</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kellum</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Peake</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Pike</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Reade</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Rowan</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Weissfeld</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Yealy</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators.</article-title>
            <source>Intensive Care Med</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>41</volume>
            <issue>9</issue>
            <fpage>1549</fpage>
            <page-range>1549-60</page-range>
            <pub-id pub-id-type="pmid">25952825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28981.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Osborn</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Severe Sepsis and Septic Shock Trials (ProCESS, ARISE, ProMISe): What is Optimal Resuscitation?</article-title>
            <source>Crit Care Clin</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>323</fpage>
            <page-range>323-344</page-range>
            <pub-id pub-id-type="pmid">28284298</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
